Noneligible Donors as a Strategy to Decrease the Organ Shortage

American Journal of Transplantation

Volumn 17, Issue 6, 2017, Pages 1649-1655

  Croome, K P ^a   Lee, D D ^a   Keaveny, A P ^a   Taner, C B ^a  

^a MAYO CLINIC   (United States)

Author keywords

clinical research practice; donors and donation: donation after circulatory death (DCD); donors and donation: extended criteria; health services and outcomes research; liver transplantation hepatology; organ procurement and allocation

Indexed keywords

ADULT; ARTICLE; BRAIN DEATH; CHOLESTASIS; CONTROLLED STUDY; FEMALE; HEART DEATH; HEPATITIS C; HUMAN; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MODEL FOR END STAGE LIVER DISEASE SCORE; NONALCOHOLIC FATTY LIVER; ORGAN DONOR; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; AGED; DEATH; DONOR; FOLLOW UP; GRAFT SURVIVAL; PROGNOSIS; RISK FACTOR; STANDARDS; SUPPLY AND DISTRIBUTION; SURVIVAL RATE; TRANSPLANTATION;

AGED; BRAIN DEATH; DEATH; FEMALE; FOLLOW-UP STUDIES; GRAFT SURVIVAL; HUMANS; MALE; ORGAN TRANSPLANTATION; PROGNOSIS; RISK FACTORS; SURVIVAL RATE; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS;

EID: 85011029475     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/ajt.14163     Document Type: Article

References (13)

1. Pruett TL, Chandraker A. The White House organ summit: What it means for our field. Am J Transplant 2016; 16: 2245–2246.
2. Israni AK, Zaun DA, Rosendale JD, et al. OPTN/SRTR 2013 annual data report: Deceased organ donation. Am J Transplant 2015; 15(S2): 1–13.
3. Croome KP, Lee DD, Keaveny AP, Taner CB. Improving national results in liver transplantation using grafts from donation after cardiac death donors. Transplantation 2016; 100: 2640–2647.
4. Laing RW, Scalera I, Isaac J, et al. Liver transplantation using grafts from donors after circulatory death: A propensity score-matched study from a single center. Am J Transplant 2016; 16: 1795–1804.
5. Grewal HP, Willingham DL, Nguyen J, Hewitt WR, Taner BC, Cornell D, et al. Liver transplantation using controlled donation after cardiac death donors: An analysis of a large single-center experience. Liver Transpl 2009; 15: 1028–1035.
6. Barbier L, Cesaretti M, Dondero F, et al. Liver transplantation with older donors: A comparison with younger donors in a context of organ shortage. Transplantation 2016; 100: 2410–2415.
7. Bertuzzo VR, Cescon M, Odaldi F, et al. Actual risk of using very aged donors for unselected liver transplant candidates: A European single-center experience in the MELD era. Ann Surg 2017; 265: 388–396.
8. Garonzik-Wang JM, James NT, Van Arendonk KJ, et al. The aggressive phenotype revisited: Utilization of higher-risk liver allografts. Am J Transplant 2013; 13: 936–942.
9. Jacobbi LM, McBride VA, Etheredge EE, et al, et al. The risks, benefits, and costs of expanding donor criteria. A collaborative prospective three-year study. Transplantation 1995; 60: 1491–1496.
10. Goldberg DS, French B, Lewis JD, et al. Liver transplant center variability in accepting organ offers and its impact on patient survival. J Hepatol 2016; 64: 843–851.
11. Croome KP, Lee DD, Burns JM, et al. The use of donation after cardiac death allografts does not increase recurrence of hepatocellular carcinoma. Am J Transplant 2015; 15: 2704–2711.
12. Croome KP, Marotta P, Wall WJ, et al. Should a lower quality organ go to the least sick patient? Model for end-stage liver disease score and donor risk index as predictors of early allograft dysfunction. Transplant Proc 2012; 44: 1303–1306.
13. Gentry SE, Massie AB, Cheek SW, et al. Addressing geographic disparities in liver transplantation through redistricting. Am J Transplant 2013; 13: 2052–2058.